Tryp Launches World-First Clinical Trial Targeting Binge Eating Disorder with TRP-8803

• Clinical Trial Research Agreement executed with Swinburne University for TRP-8803 in BED
• Trial to recruit 12 patients in two cohorts with dosing two weeks apart
• Positive Phase 2a data from University of Florida showed >80% reduction in binge eating scores
• Company holds $4.58 million cash with expected $0.9–1.0 million R&D tax refund